de
en
Reading time: approx. 13 to 16 minutes | Updated: August 2026
Germany's cannabis market in 2026 is not a single, freely accessible adult-use market. It consists of legal home growing, a commercial market for cannabis seeds and equipment, non-commercial cultivation associations, a rapidly expanding medical pharmacy market and a continuing illegal market. Germany does not have nationwide commercial shops selling adult-use cannabis.
Two years after the Cannabis Act took effect, Germany has a market moving at several different speeds. Cannabis seeds are visible online, in specialist shops and, temporarily, even at a major discounter. Cultivation associations are developing much more slowly. The strongest measurable growth is taking place in medical cannabis supplied through prescriptions and pharmacies.
Talking about “the German cannabis market” without separating these channels creates a misleading picture. This guide distinguishes commercial trade, private supply and non-commercial distribution. It also explains what current data can show and where reliable figures are still missing.
Cannabis Act
in force since 1 April 2024
Home growing
up to 3 plants per adult
Adult-use retail
no general commercial sales model
Largest measurable segment
medical cannabis
Legal notice: This market overview provides general information and is not individual legal advice. Current legislation and official authority guidance remain decisive.
Germany's cannabis market in 2026: the short answer
Germany partially legalized cannabis in 2024 but did not open a conventional adult-use market with licensed retail stores. Adults may possess and grow cannabis within statutory limits. Since July 2024, authorized cultivation associations have been able to grow collectively and provide limited quantities to members.
A commercial market for cannabis seeds, cultivation equipment and specialist information exists alongside these channels. Seeds are not ready-to-use cannabis. The largest clearly measurable legal commercial segment in 2026 is medical cannabis prescribed by doctors and dispensed through pharmacies.
Direct answer
Germany's market is divided. Adult-use supply is based mainly on private home growing and non-commercial associations. Legal commercial sales of cannabis flower take place primarily within the medical pharmacy market. Seeds and cultivation equipment form a separate legal retail segment.
Why five market segments need to be separated
Revenue forecasts for medical cannabis often dominate public descriptions of Germany's market. Those figures do not describe the entire German landscape. They do not fully capture private cultivation, seed sales, cultivation associations or informal supply.
| Segment | Basic model in 2026 | Commercial? |
|---|---|---|
| Private home growing | Personal supply within statutory limits | No; harvest may not be sold or passed to others |
| Cannabis seeds and equipment | Online retail, seed shops, specialist stores and individual retail promotions | Yes, as a seed and equipment market |
| Cultivation associations | Collective cultivation for members | No; the statutory model is non-commercial |
| Medical cannabis | Prescription and pharmacy dispensing | Yes, as a regulated pharmaceutical market |
| Illegal market | Unauthorized sales and supply | Illegal and difficult to measure reliably |
This distinction prevents a common error: growth in medical cannabis does not mean Germany has a commercial adult-use market. Legal seed sales are likewise not equivalent to retail sales of consumable cannabis flower.
What changed after 1 April 2024
The reform mainly shifted the boundaries of legal access. Certain acts that had previously been prohibited became permitted for adults within defined limits. Commercial adult-use sales remained outside the model.
New or substantially changed
- adult possession within specified limits
- private cultivation of up to three plants
- collective growing by authorized cultivation associations
- clearer access to cannabis seeds from EU Member States
- medical cannabis regulated outside Germany's Narcotics Act
What did not emerge
- no general retail sale of adult-use cannabis
- no nationwide dispensary or coffeeshop system
- no profit-oriented business model for cultivation associations
- no free distribution of privately grown harvests
- no complete dataset covering every legal and illegal quantity
The complete legal framework is covered in Cannabis in Germany 2026: rules, limits and exceptions. This guide focuses specifically on the resulting market structure.
Home growing does not create adult-use retail, but it does create a seed market
Private cultivation has an indirect economic effect. The harvest itself is not sold, but cultivation requires seeds, propagation supplies, lighting, substrates, ventilation and information. The reform therefore created no commercial market for private harvests, but it made the legal ecosystem around preparation and selection more visible.
Cannabis seeds require particular care in legal classification. According to Germany's Federal Ministry of Health, seeds for permitted private cultivation may be imported from EU Member States, purchased online and shipped to Germany. Any later cultivation remains subject to age, residence, purpose, plant limits and safeguarding requirements.
Cannabis seeds in Germany 2026: EU imports and the KCanG covers the seed rules in detail. Readers comparing seed types and genetics rather than legislation can use the main cannabis seed selection.
Market logic: Home growing replaces external supply for some adults while generating demand for seeds, equipment and reliable selection guidance. The total value of this segment cannot be calculated responsibly from plant limits or individual shop ranges.
Cannabis seeds at Netto: a small range with a large signaling effect
In March 2026, Netto Marken-Discount temporarily sold cannabis seeds from gutmut saatgut in 255 stores across Berlin and north-eastern Germany. Three strains were offered in three-seed packs for about €15. The promotion was too small to define the overall market, but its signaling effect was significant.
For the first time, cannabis seeds were displayed on a larger scale as seasonal garden seed within mainstream grocery retail. This does not show that discounters can replace specialist seed shops. It shows that cannabis seeds have moved beyond a narrowly defined subculture and are becoming visible to new customer groups.
Visibility
A familiar retail setting lowers the threshold for a first encounter with cannabis seeds.
Limit
Three promotional strains cannot represent seed bank diversity, seed types or detailed selection criteria.
Effect on specialists
As seeds become more familiar, traceable genetics, comparable product data and provenance become more important.
The dedicated guide Cannabis seeds: discounter or seed shop? compares Netto, supermarket offers and specialist retailers in detail. In this market report, the promotion serves only as evidence of the seed market's new visibility.
Cultivation associations are legal, but they are not conventional businesses
Once authorized, cultivation associations may grow cannabis collectively and provide it to members within statutory limits. They may have no more than 500 members and must operate on a non-commercial basis. Retail sales, advertising and profit orientation do not fit the German association model.
In practical supply, associations have so far played a smaller role than initially expected. The first EKOCAN interim report estimated that they covered less than 0.1% of total demand in 2024. Research published in 2026 reported that about 3.5% of surveyed consumers obtained cannabis from a cultivation association in 2025.
This is progress from the launch phase, but it is not nationwide coverage. Approval procedures, site rules, documentation, membership and the practical organization of collective growing all slow development. Implementation also differs considerably between Germany's federal states.
Cannabis Social Clubs and cultivation associations in Germany explains membership, distribution limits and association rules.
Medical cannabis is the largest clearly measurable commercial segment
Since April 2024, medical cannabis has been governed by the Medicinal Cannabis Act and is no longer treated as a narcotic under Germany's Narcotics Act. Prescribing became administratively easier, while telemedicine services, private prescription platforms and specialist pharmacies expanded.
Import data illustrate the scale of change. Germany imported around 72 tonnes of cannabis flower for medical and medical-scientific purposes in 2024. The figure rose to around 201 tonnes in 2025, followed by approximately 50.5 tonnes in the first quarter of 2026. These are import quantities, not automatic measures of retail sales, patient numbers or total German cannabis use.
| Period | Imported medical cannabis flower | Correct interpretation |
|---|---|---|
| 2024 | approx. 72 tonnes | first year under the new MedCanG from April |
| 2025 | approx. 201 tonnes | strong growth in imports and availability |
| Q1 2026 | approx. 50.5 tonnes | continued high level, not a full-year figure |
EKOCAN therefore identifies medical cannabis as the largest legal commercial access route. At the same time, policymakers are debating tighter rules for remote prescriptions and the shipping of medical cannabis flower. As of August 2026, this amendment process has not been completed. Proposed rules must not be presented as law already in force.
What the second evaluation in 2026 actually shows
The second EKOCAN interim report, published in April 2026, does not support a simple verdict of either success or failure. The available evidence points to several developments that need to be assessed separately.
| Observation | Interpretation |
|---|---|
| Prevalence of use | Stable to slightly declining among adolescents; no marked immediate change among adults after the reform |
| Problematic patterns | Some groups show indications of an increase even though population-level use did not rise sharply |
| Cannabis offences | Substantial decline, partly because specified possession and cultivation acts are no longer criminal offences |
| Legal sources | Increasing in importance, although home growing and medical supply have developed more strongly than cultivation associations |
| Prevention and counselling | Early-intervention participation and use of some support services declined, creating a need for adjustment |
For market analysis, the shift in supply routes is particularly relevant. The reform did not create general adult-use retail. It did strengthen home growing, seed purchases and medical supply as legal or permitted channels. Long-term effects cannot be determined conclusively after only two years.
Has partial legalization displaced the illegal market?
There is no final answer in 2026. EKOCAN reports indicate that legal and legally permitted sources are becoming more important, including home growing, cultivation associations and medical supply. Direct measurement of illegal sales volumes remains methodologically difficult.
A decline in recorded cannabis offences does not by itself prove an equivalent decline in the illegal market. Some of that reduction follows directly from possession and cultivation acts no longer being criminal offences. Surveys of supply sources also capture quantities, informal sharing and organized trade only imperfectly.
Evidence-based wording: Legal access routes have become more visible and important since 2024. The extent to which they have displaced illegal supply by volume has not yet been conclusively established.
Germany's cannabis market structure compared
| Question | Seeds and home growing | Cultivation associations | Medical cannabis |
|---|---|---|---|
| What is sold commercially? | Seeds, equipment and specialist services | no commercial retail | prescription medicines through pharmacies |
| How is access provided? | Specialist retail, online sales, EU shipping and general retail | membership and in-person distribution | medical prescription and pharmacy |
| How measurable is the segment? | only partly; no total dataset for private harvests | partly through permits and statutory reports | comparatively well through import, prescription and pharmacy data |
| Main development in 2026 | greater visibility and broader sales channels | slow expansion with regional differences | rapid growth and political re-regulation |
What the market shift means for specialist seed shops
In 2026, specialist seed shops face not only greater demand but a different role. Small standard ranges can now appear in mainstream retail. A specialist therefore needs to offer more than availability; it needs to provide orientation and comparability.
- Seed bank context: Who stands behind the line and how is the exact product version documented?
- Seed type: Feminized, regular, autoflower and Fast Version seeds must remain clearly separated.
- Genetic data: Cross, generation and strain family need to be traceable.
- Selection structure: Environment, timing, height and other product attributes require clear filters and guides.
- Legal classification: Seeds, living plants, harvests and ready-to-use products are separate legal levels.
This is the distinction between mass-market visibility and specialist retail. A discounter shows that cannabis seeds have entered everyday retail. A good seed shop shows how different lines can be compared responsibly.
How Germany's cannabis market may develop beyond 2026
Simple growth forecasts are not reliable. Further development will depend on legal and practical decisions in three areas.
Cultivation associations
Permitting practice, operating requirements and member access will determine whether associations achieve a larger role in legal personal supply.
Medical access
The ongoing debate about in-person consultations, telemedicine, advertising and shipping may reshape growth and distribution.
Seeds and home growing
Greater visibility is likely to increase competition. Provenance, data quality and selection architecture will become more important.
A nationwide commercial adult-use market has not been adopted in 2026. Forecasts that already include revenue from general cannabis retail stores therefore do not describe Germany's current legal model.
Related Cannoptikum guides
- Cannabis in Germany 2026: understand possession, home growing, seeds, cultivation associations and road traffic rules.
- Cannabis seeds in Germany 2026: review EU imports and the KCanG specifically for seeds.
- Cannabis Social Clubs in Germany: check membership, distribution limits and the association model.
- Cannabis seeds: discounter or seed shop?: compare Netto, supermarket ranges and specialist selection.
FAQ about Germany's cannabis market in 2026
Short: Yes, but not a general commercial adult-use market.
Long: Permitted channels include home growing within statutory limits, cannabis seed sales for lawful purposes, non-commercial cultivation associations and prescription medical cannabis. General adult-use retail stores do not exist.
Short: The medical pharmacy market shows the strongest measurable growth.
Long: Imports of medical cannabis flower increased from around 72 tonnes in 2024 to around 201 tonnes in 2025. Comparable total datasets do not exist for home growing or cannabis seed retail.
Short: No.
Long: Ready-to-use adult-use cannabis is not generally sold in retail stores. Medical cannabis requires a prescription and is dispensed by pharmacies. Cannabis seeds have a separate legal classification.
Short: Cannabis seeds are not ready-to-use cannabis and may be sold for permitted home cultivation.
Long: Netto's March 2026 promotion shows that seeds are becoming visible in mainstream retail. It did not introduce cannabis flower sales and cannot replace the range or guidance of a specialist seed shop.
Short: No.
Long: Cultivation associations organize collective, non-commercial growing for members. Distribution, membership, quantities, documentation and youth protection are governed by statutory requirements.
Short: No.
Long: Legal sources are gaining importance, but displacement of illegal supply cannot yet be measured conclusively by volume. Offence statistics, surveys and import data each capture only part of the market.
Short: No. The amendment process had not been completed by August 2026.
Long: Proposals include in-person doctor consultations and restrictions on shipping medical cannabis flower. Draft proposals and currently applicable law must remain clearly separated until the legislative process is complete.
Sources and data status
- German Federal Ministry of Health: Cannabis Act FAQ
- EKOCAN: Second interim evaluation report, April 2026
- BfArM: Medical cannabis import and export statistics
- German Federal Ministry of Health: ongoing MedCanG amendment process
- MDR: Netto cannabis seed trial, March 2026
Import figures refer to cannabis flower for medical and medical-scientific purposes. They are not equivalent to end-customer revenue, consumption or patient numbers.
Conclusion
Germany's cannabis market in 2026 is larger and more visible than before partial legalization, but it is not freely commercialized. Home growing supports demand for seeds, equipment and information. Cultivation associations remain non-commercial and are expanding slowly. The strongest measurable growth is found in medical cannabis. Any serious description of the German market must keep these segments separate and state the remaining data gaps openly.